Barriers and Strategies: A Review of Access to Affordable Multi-Drug Resistant Tuberculosis Medication in China.

Zhang, Yuou; Liu, Xuan; Yang, Linghe; Zhang, Guifang; Gu, Zhaoru; Chen, Zhongdan; Sun, Jing

Zhang, Yuou; Liu, Xuan; Yang, Linghe; Zhang, Guifang; Gu, Zhaoru; Chen, Zhongdan; Sun, Jing.

Afiliação

Zhang Y; School of Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Liu X; School of Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Yang L; School of Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Zhang G; Institute of Geriatrics, Beijing Hospital, Beijing, People's Republic of China.
Gu Z; Institute of Cancer, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Chen Z; Hepatitis/TB/HIV/STI, World Health Organization, Office of the WHO Representative in China, Beijing, People's Republic of China.
Sun J; School of Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Infect Drug Resist ; 13: 3679-3687, 2020.

Article em En | MEDLINE | ID: mdl-33116687

Palavras-chave

MDR-TB; affordable; financing; medication; off-label use; repurposed medicines; safety-net

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 3_ND Base de dados: MEDLINE Idioma: En Revista: Infect Drug Resist Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google